Sharmini Alagaratnam

573 total citations
14 papers, 408 citations indexed

About

Sharmini Alagaratnam is a scholar working on Surgery, Molecular Biology and Genetics. According to data from OpenAlex, Sharmini Alagaratnam has authored 14 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Sharmini Alagaratnam's work include Testicular diseases and treatments (5 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (4 papers) and Cancer Genomics and Diagnostics (4 papers). Sharmini Alagaratnam is often cited by papers focused on Testicular diseases and treatments (5 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (4 papers) and Cancer Genomics and Diagnostics (4 papers). Sharmini Alagaratnam collaborates with scholars based in Norway, United Kingdom and Netherlands. Sharmini Alagaratnam's co-authors include Ragnhild A. Lothe, Rolf I. Skotheim, Sigrid Marie Kraggerud, Peter W. Andrews, Adam J. Hirst, Stuart Avery, Chin Yan Lim, Christina Engel Hoei‐Hansen, Vera M. Abeler and Duncan Baker and has published in prestigious journals such as Journal of Clinical Oncology, Endocrine Reviews and Cancer Research.

In The Last Decade

Sharmini Alagaratnam

14 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharmini Alagaratnam Norway 10 271 81 80 74 57 14 408
Yong Sam Shin South Korea 12 278 1.0× 102 1.3× 69 0.9× 106 1.4× 60 1.1× 18 501
Rana Abdel‐Fattah United States 10 212 0.8× 95 1.2× 108 1.4× 80 1.1× 29 0.5× 11 421
Julian Gehring Germany 2 297 1.1× 55 0.7× 152 1.9× 58 0.8× 43 0.8× 3 393
A Koch Germany 8 180 0.7× 38 0.5× 96 1.2× 80 1.1× 101 1.8× 11 339
Wendy J. Ingram Australia 7 267 1.0× 29 0.4× 41 0.5× 62 0.8× 44 0.8× 10 346
Roberto Rosati Italy 11 361 1.3× 49 0.6× 93 1.2× 36 0.5× 44 0.8× 20 626
Christopher J. Vallorosi United States 4 194 0.7× 81 1.0× 33 0.4× 101 1.4× 24 0.4× 5 352
Yoko Sekita Japan 6 362 1.3× 34 0.4× 164 2.0× 81 1.1× 53 0.9× 7 511
Astrid Escudero‐Esparza United Kingdom 8 193 0.7× 25 0.3× 107 1.3× 95 1.3× 33 0.6× 9 399
Huajie Bu Austria 10 355 1.3× 24 0.3× 188 2.4× 76 1.0× 44 0.8× 11 510

Countries citing papers authored by Sharmini Alagaratnam

Since Specialization
Citations

This map shows the geographic impact of Sharmini Alagaratnam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharmini Alagaratnam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharmini Alagaratnam more than expected).

Fields of papers citing papers by Sharmini Alagaratnam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharmini Alagaratnam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharmini Alagaratnam. The network helps show where Sharmini Alagaratnam may publish in the future.

Co-authorship network of co-authors of Sharmini Alagaratnam

This figure shows the co-authorship network connecting the top 25 collaborators of Sharmini Alagaratnam. A scholar is included among the top collaborators of Sharmini Alagaratnam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharmini Alagaratnam. Sharmini Alagaratnam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Berg, Kaja C. G., Anita Sveen, Sharmini Alagaratnam, et al.. (2020). Genomic and prognostic heterogeneity among RAS/BRAFV600E/TP53 co‐mutated resectable colorectal liver metastases. Molecular Oncology. 15(4). 830–845. 11 indexed citations
2.
Hoff, Andreas, Sigrid Marie Kraggerud, Sharmini Alagaratnam, et al.. (2020). Frequent copy number gains of SLC2A3 and ETV1 in testicular embryonal carcinomas. Endocrine Related Cancer. 27(9). 457–468. 5 indexed citations
3.
Berg, Kaja C. G., Anita Sveen, Maren Høland, et al.. (2019). Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains. Oncogene. 38(33). 6109–6122. 20 indexed citations
4.
Sveen, Anita, Inger Marie Løes, Sharmini Alagaratnam, et al.. (2016). Intra-individual genetic heterogeneity among liver metastases in metastatic colorectal cancer.. Journal of Clinical Oncology. 34(4_suppl). 555–555. 1 indexed citations
5.
Sveen, Anita, Inger Marie Løes, Sharmini Alagaratnam, et al.. (2016). Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection. PLoS Genetics. 12(7). e1006225–e1006225. 47 indexed citations
6.
Hoff, Andreas, Sharmini Alagaratnam, Sen Zhao, et al.. (2015). Identification of Novel Fusion Genes in Testicular Germ Cell Tumors. Cancer Research. 76(1). 108–116. 19 indexed citations
7.
Hoff, Andreas, Bjarne Johannessen, Sharmini Alagaratnam, et al.. (2015). Novel RNA variants in colorectal cancers. Oncotarget. 6(34). 36587–36602. 13 indexed citations
8.
Avery, Stuart, Adam J. Hirst, Duncan Baker, et al.. (2013). BCL-XL Mediates the Strong Selective Advantage of a 20q11.21 Amplification Commonly Found in Human Embryonic Stem Cell Cultures. Stem Cell Reports. 1(5). 379–386. 115 indexed citations
9.
Kraggerud, Sigrid Marie, Christina Engel Hoei‐Hansen, Sharmini Alagaratnam, et al.. (2013). Molecular Characteristics of Malignant Ovarian Germ Cell Tumors and Comparison With Testicular Counterparts: Implications for Pathogenesis. Endocrine Reviews. 34(3). 339–376. 67 indexed citations
10.
Alagaratnam, Sharmini, Neil A. Harrison, Anne Cathrine Bakken, et al.. (2012). Transforming Pluripotency: An Exon-Level Study of Malignancy-Specific Transcripts in Human Embryonal Carcinoma and Embryonic Stem Cells. Stem Cells and Development. 22(7). 1136–1146. 11 indexed citations
11.
Nadarajah, Vishna Devi, et al.. (2012). Serum Peptide Profiles of Duchenne Muscular Dystrophy (DMD) Patients Evaluated by Data Handling Strategies for High Resolution Content. Journal of Proteomics & Bioinformatics. 5(4). 8 indexed citations
12.
Alagaratnam, Sharmini, Guro E. Lind, Sigrid Marie Kraggerud, Ragnhild A. Lothe, & Rolf I. Skotheim. (2011). The testicular germ cell tumour transcriptome. International Journal of Andrology. 34(4pt2). e133–50; discussion e150. 38 indexed citations
13.
Alagaratnam, Sharmini, Bart Mertens, André M. Deelder, et al.. (2008). Serum protein profiling in mice: Identification of Factor XIIIa as a potential biomarker for muscular dystrophy. PROTEOMICS. 8(8). 1552–1563. 47 indexed citations
14.
Alagaratnam, Sharmini, et al.. (2008). TPD52, a candidate gene from genomic studies, is overexpressed in testicular germ cell tumours. Molecular and Cellular Endocrinology. 306(1-2). 75–80. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026